Procalcitonin (PCT) Assay Market Outlook (2023 to 2033)

The procalcitonin (PCT) assay market size is projected to be worth US$ 280.6 million in 2023. The market is likely to surpass US$ 512.9 million by 2033 at a CAGR of 6.2% during the forecast period. Growing lung cancer incidences is aiding the market growth. The PCT assay market has seen significant growth in recent years due to the increasing awareness about the importance of early and accurate diagnosis of bacterial infections The Procalcitonin (PCT) assay refers to the market for diagnostic tests that measure the levels of procalcitonin in the bloodstream. Procalcitonin is a precursor protein to the hormone calcitonin and is produced in response to bacterial infections.

Other Drivers Propelling the Demand for Procalcitonin (PCT) Assay Market include:

  • Bacterial infections continue to be a significant global health concern. The rising incidence of infectious diseases, such as pneumonia, sepsis, and other bacterial infections, has led to an increased demand for accurate diagnostic tests like PCT assays.
  • Antibiotic stewardship, which tries to optimize antibiotic use in order to stop the emergence of antibiotic resistance, is receiving more attention. By enabling medical practitioners in distinguishing between bacterial and viral infections, PCT assays are essential in antibiotic stewardship initiatives. PCT tests improve patient outcomes and help fight antibiotic resistance by assisting in the reduction of needless antibiotic prescriptions.
  • PCT assays have gained widespread acceptance and adoption in clinical practice, particularly in settings such as hospitals, emergency departments, and intensive care units. Healthcare professionals recognize the value of PCT assays in aiding clinical decision-making, guiding antibiotic therapy, and monitoring treatment response. This increased utilization of PCT assays is driving market demand.

Challenges for Companies /Manufacturers in the Procalcitonin (PCT) Assay Market:

  • Manufacturers of PCT tests must adhere with regulatory regulations and obtain the required approvals and certifications to ensure the safety, efficacy, and quality of their products. It can be challenging and costly to get through the regulatory processes, and the regulatory landscape may differ between various regions.
  • Despite rising awareness of PCT tests, there is still a need for practitioner education and understanding of their clinical value and interpretation. Healthcare practitioners need to be aware of the usefulness of PCT assays, how to use them properly, and how to interpret test findings.
  • The cost of PCT tests is a key factor influencing their adoption. Although there is a growing need for PCT tests, their availability may be constrained by cost, particularly in settings with limited resources. To make their tests accessible without sacrificing quality, manufacturers must strike a compromise between development costs, manufacturing costs, and price strategies.

Opportunities in the Procalcitonin (PCT) Assay Market Industry:

  • The continuous advancements in assay technology have contributed to the growth of the PCT assay market. The development of automated platforms, point-of-care testing options, and rapid diagnostic methods has made PCT testing more accessible, efficient, and cost-effective. These technological advancements have expanded the potential applications of PCT assays and fueled their demand in various healthcare settings.
  • The healthcare industry is increasingly moving towards personalized medicine, where diagnostic tests play a crucial role in tailoring treatment to individual patients. PCT assays provide valuable information to healthcare professionals for personalized treatment decisions.
  • The overall increase in healthcare expenditure, particularly in emerging economies, is contributing to the growth of the PCT assay market.

Latest Trends in the Procalcitonin (PCT) Assay Market:

  • There is a growing trend towards point-of-care testing, which enables rapid and near-patient testing without the need for complex laboratory infrastructure. POCT PCT assays are gaining popularity due to their potential for immediate results and their utility in emergency departments, critical care settings, and ambulatory care.
  • AI and machine learning algorithms are being integrated into PCT assay analysis to enhance diagnostic accuracy and aid in clinical decision-making.
  • The development of multiplex assays that can simultaneously measure multiple biomarkers, including PCT, is gaining traction. Multiplexing enables the detection of multiple analytes in a single test, saving time and resources.
Attributes Details
Procalcitonin (PCT) Assay Market Size (2023) US$ 280.6 million
Procalcitonin (PCT) Assay Market Projected Size (2033) US$ 512.9 million
Value CAGR (2023 to 2033) 6.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2012 to 2022 Procalcitonin (PCT) Assay Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global procalcitonin (PCT) assay market experienced a CAGR of 3.0%, reaching a market size of US$ 280.6 million in 2023.

The global procalcitonin (PCT) assay market witnessed steady growth in the past and is expected to continue to develop at a significant pace due to their increasing demand in non-hospital settings, such as primary care clinics and outpatient facilities. The increasing availability of PCT testing options, including point-of-care devices, facilitates broader access to PCT testing and supports early diagnosis and appropriate management of bacterial infections in various healthcare settings.

With the rising concern of antibiotic resistance, there is an increased emphasis on antibiotic stewardship programs. PCT assays play a vital role in these programs by assisting clinicians in determining the need for antibiotic therapy, optimizing treatment duration, and monitoring response to treatment. This is also leading to enhanced integration of PCT testing into antibiotic stewardship protocols.

Future Forecast for Procalcitonin (PCT) Assay Market Industry:

Looking ahead, the global procalcitonin (PCT) assay market is expected to rise at a CAGR of 6.2% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 512.9 million by 2033.

PCT is increasingly being used as part of biomarker panels or algorithms to improve the accuracy of infection diagnosis and prognosis. Combining PCT with other biomarkers, such as C-reactive protein (CRP) or proadrenomedullin (MR-proADM), can provide a more comprehensive assessment of the severity and course of an infection, this could likely increase the sales of PCT assays in the coming times.

Collaboration between diagnostic companies, assay manufacturers, and healthcare providers is becoming more prevalent. Partnerships and collaborations among manufactures will combine expertise, resources, and technologies to develop innovative PCT assays, improve accessibility, and expand market reach. These partnerships can lead to the development of integrated diagnostic solutions and improved patient care.

Country-Wise Insights

Which Factors are leading the Procalcitonin (PCT) Assay Market to Surge in the United States?

Country The United States
Market Size (US$ Million) by End of Forecast Period (2033) US$ 202.0 million
CAGR % 2023 to End of Forecast (2033) 7.3%

The procalcitonin (PCT) assay market in the United States is expected to reach a market size of US$ 202.0 million by 2033, expanding at a CAGR of 7.3%. The United States has been experiencing a rising incidence of bacterial infections, including community-acquired pneumonia, sepsis, and urinary tract infections. This has heightened the need for accurate and timely diagnosis to guide appropriate treatment decisions. PCT assays offer valuable insights for differentiating bacterial from viral infections, aiding in the diagnosis and management of these conditions.

Rising Demand for Procalcitonin (PCT) Assay Market is Due to Well Developed Reimbursement Support.

Country The United Kingdom
Market Size (US$ Million) by End of Forecast Period (2033) US$ 26.4 million
CAGR % 2023 to End of Forecast (2033) 8.3%

The procalcitonin (PCT) assay market in the United Kingdom is expected to reach a market value of US$ 26.4 million, expanding at a CAGR of 8.3% during the forecast period. The availability of favorable reimbursement policies for PCT testing has played a role in the market growth of PCT assays in the UK. Reimbursement coverage by public and private payers incentivizes healthcare providers to adopt and utilize PCT assays, ensuring proper compensation for the testing services provided.

Notable Growth Expected in China's Procalcitonin (PCT) Assay Market as Enhanced Awareness and Education.

Country China
Market Size (US$ Million) by End of Forecast Period (2033) US$ 62.7 million
CAGR % 2023 to End of Forecast (2033) 9.1%

The procalcitonin (PCT) assay market in China is anticipated to reach a market size of US$ 62.7 million by the end of 2033, growing at a CAGR of 9.1% throughout the forecast period. There has been a significant increase in awareness among healthcare professionals in China about the clinical utility and benefits of PCT testing. Educational initiatives, conferences, and scientific publications have contributed to the dissemination of knowledge regarding PCT assays and their role in infection management. This improved awareness has led to increased demand for PCT assays in the country.

Advanced Healthcare Infrastructure to Drive Market Growth in Japan

Country Japan
Market Size (US$ Million) by End of Forecast Period (2033) US$ 20.8 million
CAGR % 2023 to End of Forecast (2033) 6.7%

The procalcitonin (PCT) assay market in Japan is estimated to reach a market size of US$ 20.8 million by 2033, expected to thrive at a CAGR of 6.7%. Technological advancements have improved the accessibility and efficiency of PCT assays. Automated platforms, rapid testing options, and point-of-care devices have made PCT testing more convenient and streamlined in various healthcare settings. These advancements have facilitated the integration of PCT assays into routine clinical practice, leading to their surge in the Japan.

Demand for Procalcitonin (PCT) Assay Market is Rising Due to Strong Healthcare Infrastructure.

Country South Korea
Market Size (US$ Million) by End of Forecast Period (2033) US$ 13.9 million
CAGR % 2023 to End of Forecast (2033) 6.0%

The procalcitonin (PCT) assay market in South Korea is expected to reach a market size of US$ 13.9 million, expanding at a CAGR of 6.0% during the forecast period. South Korea has a robust healthcare infrastructure, including hospitals, clinics, and diagnostic laboratories. This infrastructure supports the implementation and utilization of PCT assays in routine practice. The presence of well-equipped healthcare facilities and the availability of trained personnel contribute to the increased demand for PCT assays in the country.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-Wise Insights

Serum Sample to Dominate Procalcitonin (PCT) Assay Market Industry with 55.0% Market Share in 2022

Serum sample dominated the procalcitonin (PCT) assay market with a market share of 34.2% in 2022. Collecting serum samples is a routine and minimally invasive procedure. Blood samples can be easily obtained through venipuncture and processed to separate serum and plasma from other blood components. This simplicity and familiarity make serum a convenient sample type for PCT assay testing.

Which Product is Predominantly in Demand in the Global Scenario?

Based on products, test kits have dominated the category withholding the significant share of the market at around 68.7% at the end of 2022. Test kits for PCT assays are readily available in the market from multiple manufacturers. This wide availability ensures that laboratories and healthcare facilities have access to a variety of options, allowing them to select the test kit that best fits their specific requirements in terms of performance, cost, and workflow compatibility.

Which Segment is Expected to Lead the ‘Purpose’ Category Throughout the Forecast Period?

By purpose, clinical use segment is expected to continue leading the market over a CAGR of 6.0% throughout the projected timeframe. PCT assays have proven clinical utility in the diagnosis of bacterial infections, especially severe infections such as sepsis. PCT levels in the bloodstream rise significantly in response to bacterial infections, making it a valuable biomarker for differentiating bacterial from viral infections. This diagnostic value has led to the widespread adoption of PCT assays in clinical practice for guiding antibiotic therapy and supporting clinical decision-making.

Which End User Has Widely Adopted the PCT Assay?

The hospitals have led the procalcitonin (PCT) assay market as the leading end user with the market share of 36.7% in 2022. Hospitals are primary providers of acute care, dealing with a wide range of patients, including those with severe infections, sepsis, and other critical conditions. PCT assays have significant clinical utility in these settings, aiding in the diagnosis, monitoring, and management of bacterial infections. Hospitals rely on PCT assays to support clinical decision-making, guide antibiotic therapy, and assess patient prognosis in these acute care scenarios.

How Key Players Stay Competitive in the Procalcitonin (PCT) Assay Market Industry?

By employing these strategies, key players in the PCT assay market can enhance their competitiveness, differentiate their offerings, and maintain a strong market presence. Continuous innovation, strategic partnerships, effective marketing, and customer-centric approaches are crucial for sustained success in this competitive industry.

Key Strategies Used by the Participants

  • Product Innovation

Key players continuously invest in research and development to introduce innovative PCT assay products. They strive to develop assays with improved sensitivity, specificity, accuracy, and ease of use.

  • Strategic Partnerships and Collaborations

Key players often form strategic partnerships and collaborations with other companies, research institutions, and healthcare organizations. These partnerships can lead to knowledge sharing, joint product development, and expanded market reach.

  • Expansion into Emerging Markets

Expanding into emerging markets with growing healthcare infrastructure and rising demand for PCT assays allows companies to tap into new opportunities and gain a competitive edge.

  • Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to streamline their product portfolio, obtain new technologies, enter new market niches, and gain access to novel products or intellectual property.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players in the Procalcitonin (PCT) Assay Market Industry

  • J. Mitra & Co. Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Elabscience Biotechnology Inc.
  • CUSABIO TECHNOLOGY LLC
  • Wuhan Fine Biotech Co., Ltd.
  • Company ABclonal, Inc.
  • Nanjing Vazyme Biotech Co.,Ltd.
  • RayBiotech Life, Inc.
  • Hipro Biotechnology Co.,Ltd.
  • Vitrosens Biotechnology
  • bioMérieux SA
  • ELK Biotechnology CO.,Ltd.
  • Immuno-Biological Laboratories, Inc.
  • BISAF
  • Roche Diagnostics

Key Developments in the Procalcitonin (PCT) Assay Market:

  • In November 2020, Roche and bioMérieux announced a collaboration to improve antibiotic stewardship by developing and providing PCT assays on Roche's cobas platforms.
  • In February 2020, bioMérieux received FDA clearance for the Vidas BRAHMS PCT assay, which is an automated immunoassay platform for measuring PCT levels.

Segmentation Analysis of the Procalcitonin (PCT) Assay Market

By Sample Type:

  • Serum
  • Plasma
  • Cell Culture Medium
  • Other Biological Fluids

By Product:

  • Test Kits
    • Procalcitonin ELISA test kits
    • Procalcitonin CLIA kits
    • PCT Immunochromatography KITS
    • PCT Rapid Test Kit
  • Analyzer & Instruments
  • Consumables

By Purpose:

  • Clinical Use
  • Research Use Only

By End User:

  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

What is the Current Worth of the Procalcitonin (PCT) Assay Market?

The global procalcitonin (PCT) assay market is expected to reach a valuation of US$ 280.6 million by 2023.

How is the Demand for Procalcitonin (PCT) Assay Market Increasing?

The procalcitonin (PCT) assay market demand is set to expand by 6.2% during the assessment period.

Which Product Holds the Notable Market Share in the Global Procalcitonin (PCT) Assay Market?

The test kits segment is projected to hold the dominant share of the market.

What is the Predicted Valuation of the Procalcitonin (PCT) Assay Market by 2033?

The market is predicted to exceed US$ 512.9 million by 2033.

Which is the Most Profitable Region for the Procalcitonin (PCT) Assay Market Industry?

The North America offers key opportunities for new entrants in the procalcitonin (PCT) assay market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation/Development Trends

4. Value Added Insights

    4.1. Product Adoption / Usage Analysis, by Region

    4.2. New Product Launches

    4.3. Regulatory Landscape, By Country

    4.4. PESTEL Analysis

    4.5. Porter’s Five Force Analysis

    4.6. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Immunoassay Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Incidence of Sepsis and Infectious Diseases

        5.2.2. Growing Emphasis on Antibiotic Stewardship

        5.2.3. Increasing Awareness about PCT as a Biomarker

        5.2.4. Continuous Advancements in Assay Technologies, Including Immunoassays, Molecular Diagnostics, and Point-Of-Care Testing

        5.2.5. Expansion into Non-Hospital Settings

        5.2.6. Investments in Research and Development

        5.2.7. Emerging Markets and Increased Healthcare Spending

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunities

6. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2012 to 2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market Demand Pricing Analysis 2012 to 2022 and Forecast, 2023 to 2033

    7.1. Regional Pricing Analysis

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    8.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

    8.2. Historical Market Value (US$ Million) Analysis, 2012 to 2022

    8.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.3.1. Y-o-Y Growth Trend Analysis

        8.3.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2012 to 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        9.3.1. Serum

        9.3.2. Plasma

        9.3.3. Cell Culture Medium

        9.3.4. Other Biological Fluids

    9.4. Market Attractiveness Analysis By Sample Type

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Unit) By Product, 2012 to 2022

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        10.3.1. Test Kits

            10.3.1.1. Procalcitonin ELISA test kits

            10.3.1.2. Procalcitonin CLIA kits

            10.3.1.3. PCT Immunochromatography KITS

            10.3.1.4. PCT Rapid Test Kit

        10.3.2. Analyzer & Instrument

        10.3.3. Consumable

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Purpose, 2012 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Purpose, 2023 to 2033

        11.3.1. Clinical Use

        11.3.2. Research Use Only

    11.4. Market Attractiveness Analysis By Purpose

12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        12.3.1. Hospital

        12.3.2. Specialty Clinics

        12.3.3. Academic and Research Institute

        12.3.4. Diagnostics Laboratories

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Region, 2012 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. USA

            14.3.1.2. Canada

        14.3.2. By Sample Type

        14.3.3. By Product

        14.3.4. By Purpose

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Sample Type

        14.4.3. By Product

        14.4.4. By Purpose

        14.4.5. By End User

    14.5. Market Trends

    14.6. Market Drivers & Restraints – Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. USA Market

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Sample Type

                14.7.1.2.2. By Product

                14.7.1.2.3. By Purpose

                14.7.1.2.4. By End User

        14.7.2. Canada Market

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Sample Type

                14.7.2.2.2. By Product

                14.7.2.2.3. By Purpose

                14.7.2.2.4. By End User

15. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of LATAM

        15.3.2. By Sample Type

        15.3.3. By Product

        15.3.4. By Purpose

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Sample Type

        15.4.3. By Product

        15.4.4. By Purpose

        15.4.5. By End User

    15.5. Market Trends

    15.6. Market Drivers & Restraints – Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Brazil Market

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Sample Type

                15.7.1.2.2. By Product

                15.7.1.2.3. By Purpose

                15.7.1.2.4. By End User

        15.7.2. Mexico Market

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Sample Type

                15.7.2.2.2. By Product

                15.7.2.2.3. By Purpose

                15.7.2.2.4. By End User

        15.7.3. Argentina Market

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Sample Type

                15.7.3.2.2. By Product

                15.7.3.2.3. By Purpose

                15.7.3.2.4. By End User

16. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. UK

            16.3.1.2. Germany

            16.3.1.3. France

            16.3.1.4. Italy

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Sample Type

        16.3.3. By Product

        16.3.4. By Purpose

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Sample Type

        16.4.3. By Product

        16.4.4. By Purpose

        16.4.5. By End User

    16.5. Market Trends

    16.6. Market Drivers & Restraints – Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. UK Market

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Sample Type

                16.7.1.2.2. By Product

                16.7.1.2.3. By Purpose

                16.7.1.2.4. By End User

        16.7.2. Germany Market

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Sample Type

                16.7.2.2.2. By Product

                16.7.2.2.3. By Purpose

                16.7.2.2.4. By End User

        16.7.3. France Market

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Sample Type

                16.7.3.2.2. By Product

                16.7.3.2.3. By Purpose

                16.7.3.2.4. By End User

        16.7.4. Italy Market

            16.7.4.1. Introduction

            16.7.4.2. Market Analysis and Forecast by Market Taxonomy

                16.7.4.2.1. By Sample Type

                16.7.4.2.2. By Product

                16.7.4.2.3. By Purpose

                16.7.4.2.4. By End User

        16.7.5. Spain Market

            16.7.5.1. Introduction

            16.7.5.2. Market Analysis and Forecast by Market Taxonomy

                16.7.5.2.1. By Sample Type

                16.7.5.2.2. By Product

                16.7.5.2.3. By Purpose

                16.7.5.2.4. By End User

        16.7.6. BENELUX Market

            16.7.6.1. Introduction

            16.7.6.2. Market Analysis and Forecast by Market Taxonomy

                16.7.6.2.1. By Sample Type

                16.7.6.2.2. By Purpose

                16.7.6.2.3. By Product

                16.7.6.2.4. By End User

        16.7.7. Russia Market

            16.7.7.1. Introduction

            16.7.7.2. Market Analysis and Forecast by Market Taxonomy

                16.7.7.2.1. By Sample Type

                16.7.7.2.2. By Product

                16.7.7.2.3. By Purpose

                16.7.7.2.4. By End User

17. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Sample Type

        17.3.3. By Product

        17.3.4. By Purpose

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Sample Type

        17.4.3. By Product

        17.4.4. By Purpose

        17.4.5. By End User

    17.5. Market Trends

    17.6. Market Drivers & Restraints – Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. China Market

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Sample Type

                17.7.1.2.2. By Product

                17.7.1.2.3. By Purpose

                17.7.1.2.4. By End User

        17.7.2. Japan Market

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Sample Type

                17.7.2.2.2. By Product

                17.7.2.2.3. By Purpose

                17.7.2.2.4. By End User

        17.7.3. South Korea Market

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Sample Type

                17.7.3.2.2. By Product

                17.7.3.2.3. By Purpose

                17.7.3.2.4. By End User

18. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Indonesia

            18.3.1.3. Thailand

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Sample Type

        18.3.3. By Product

        18.3.4. By Purpose

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Sample Type

        18.4.3. By Product

        18.4.4. By Purpose

        18.4.5. By End User

    18.5. Market Trends

    18.6. Market Drivers & Restraints – Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. India Market

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Sample Type

                18.7.1.2.2. By Product

                18.7.1.2.3. By Purpose

                18.7.1.2.4. By End User

        18.7.2. Indonesia Market

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Sample Type

                18.7.2.2.2. By Product

                18.7.2.2.3. By Purpose

                18.7.2.2.4. By End User

        18.7.3. Thailand Market

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Sample Type

                18.7.3.2.2. By Product

                18.7.3.2.3. By Purpose

                18.7.3.2.4. By End User

        18.7.4. Malaysia Market

            18.7.4.1. Introduction

            18.7.4.2. Market Analysis and Forecast by Market Taxonomy

                18.7.4.2.1. By Sample Type

                18.7.4.2.2. By Product

                18.7.4.2.3. By Purpose

                18.7.4.2.4. By End User

19. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Sample Type

        19.3.3. By Product

        19.3.4. By Purpose

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Sample Type

        19.4.3. By Product

        19.4.4. By Purpose

        19.4.5. By End User

    19.5. Market Trends

    19.6. Market Drivers & Restraints – Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. Australia Market

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast by Market Taxonomy

                19.7.1.2.1. By Sample Type

                19.7.1.2.2. By Product

                19.7.1.2.3. By Purpose

                19.7.1.2.4. By End User

        19.7.2. New Zealand Market

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast by Market Taxonomy

                19.7.2.2.1. By Sample Type

                19.7.2.2.2. By Product

                19.7.2.2.3. By Purpose

                19.7.2.2.4. By End User

20. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Türkiye

            20.3.1.3. South Africa

            20.3.1.4. Northern Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Sample Type

        20.3.3. By Product

        20.3.4. By Purpose

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Sample Type

        20.4.3. By Product

        20.4.4. By Purpose

        20.4.5. By End User

    20.5. Market Trends

    20.6. Market Drivers & Restraints – Impact Analysis

    20.7. Country Level Analysis & Forecast

        20.7.1. GCC Countries Market

            20.7.1.1. Introduction

            20.7.1.2. Market Analysis and Forecast by Market Taxonomy

                20.7.1.2.1. By Sample Type

                20.7.1.2.2. By Product

                20.7.1.2.3. By Purpose

                20.7.1.2.4. By End User

        20.7.2. Türkiye Market

            20.7.2.1. Introduction

            20.7.2.2. Market Analysis and Forecast by Market Taxonomy

                20.7.2.2.1. By Sample Type

                20.7.2.2.2. By Product

                20.7.2.2.3. By Purpose

                20.7.2.2.4. By End User

        20.7.3. South Africa Market

            20.7.3.1. Introduction

            20.7.3.2. Market Analysis and Forecast by Market Taxonomy

                20.7.3.2.1. By Sample Type

                20.7.3.2.2. By Product

                20.7.3.2.3. By Purpose

                20.7.3.2.4. By End User

        20.7.4. Northern Africa Market

            20.7.4.1. Introduction

            20.7.4.2. Market Analysis and Forecast by Market Taxonomy

                20.7.4.2.1. By Sample Type

                20.7.4.2.2. By Product

                20.7.4.2.3. By Purpose

                20.7.4.2.4. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Maternity Care Types)

    21.2. Market Share Analysis of Top Players

    21.3. Market Concentration

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Branding and Promotional Strategies, By key Players

    22.3. Key Development Analysis

    22.4. Competition Deep Dive

        22.4.1. Thermo Fisher Scientific Inc.

            22.4.1.1. Overview

            22.4.1.2. Type Portfolio

            22.4.1.3. Key Financials

            22.4.1.4. SWOT Analysis

            22.4.1.5. Key Developments

            22.4.1.6. Sales Footprint

            22.4.1.7. Strategy Overview

                22.4.1.7.1. Marketing Strategy

                22.4.1.7.2. Type Strategy

                22.4.1.7.3. Channel Strategy

        22.4.2. J. Mitra & Co. Pvt. Ltd.

            22.4.2.1. Overview

            22.4.2.2. Type Portfolio

            22.4.2.3. Key Financials

            22.4.2.4. SWOT Analysis

            22.4.2.5. Key Developments

            22.4.2.6. Sales Footprint

            22.4.2.7. Strategy Overview

                22.4.2.7.1. Marketing Strategy

                22.4.2.7.2. Type Strategy

                22.4.2.7.3. Channel Strategy

        22.4.3. Thermo Fisher Scientific Inc.

            22.4.3.1. Overview

            22.4.3.2. Type Portfolio

            22.4.3.3. Key Financials

            22.4.3.4. SWOT Analysis

            22.4.3.5. Key Developments

            22.4.3.6. Sales Footprint

            22.4.3.7. Strategy Overview

                22.4.3.7.1. Marketing Strategy

                22.4.3.7.2. Type Strategy

                22.4.3.7.3. Channel Strategy

        22.4.4. Elabscience Biotechnology Inc.

            22.4.4.1. Overview

            22.4.4.2. Type Portfolio

            22.4.4.3. Key Financials

            22.4.4.4. SWOT Analysis

            22.4.4.5. Key Developments

            22.4.4.6. Sales Footprint

            22.4.4.7. Strategy Overview

                22.4.4.7.1. Marketing Strategy

                22.4.4.7.2. Type Strategy

                22.4.4.7.3. Channel Strategy

        22.4.5. CUSABIO TECHNOLOGY LLC

            22.4.5.1. Overview

            22.4.5.2. Type Portfolio

            22.4.5.3. Key Financials

            22.4.5.4. SWOT Analysis

            22.4.5.5. Key Developments

            22.4.5.6. Sales Footprint

            22.4.5.7. Strategy Overview

                22.4.5.7.1. Marketing Strategy

                22.4.5.7.2. Type Strategy

                22.4.5.7.3. Channel Strategy

        22.4.6. Wuhan Fine Biotech Co., Ltd.

            22.4.6.1. Overview

            22.4.6.2. Type Portfolio

            22.4.6.3. Key Financials

            22.4.6.4. SWOT Analysis

            22.4.6.5. Key Developments

            22.4.6.6. Sales Footprint

            22.4.6.7. Strategy Overview

                22.4.6.7.1. Marketing Strategy

                22.4.6.7.2. Type Strategy

                22.4.6.7.3. Channel Strategy

        22.4.7. Company ABclonal, Inc.

            22.4.7.1. Overview

            22.4.7.2. Type Portfolio

            22.4.7.3. Key Financials

            22.4.7.4. SWOT Analysis

            22.4.7.5. Key Developments

            22.4.7.6. Sales Footprint

            22.4.7.7. Strategy Overview

                22.4.7.7.1. Marketing Strategy

                22.4.7.7.2. Type Strategy

                22.4.7.7.3. Channel Strategy

        22.4.8. Nanjing Vazyme Biotech Co.,Ltd.

            22.4.8.1. Overview

            22.4.8.2. Type Portfolio

            22.4.8.3. Key Financials

            22.4.8.4. SWOT Analysis

            22.4.8.5. Key Developments

            22.4.8.6. Sales Footprint

            22.4.8.7. Strategy Overview

                22.4.8.7.1. Marketing Strategy

                22.4.8.7.2. Type Strategy

                22.4.8.7.3. Channel Strategy

        22.4.9. RayBiotech Life, Inc.

            22.4.9.1. Overview

            22.4.9.2. Type Portfolio

            22.4.9.3. Key Financials

            22.4.9.4. SWOT Analysis

            22.4.9.5. Key Developments

            22.4.9.6. Sales Footprint

            22.4.9.7. Strategy Overview

                22.4.9.7.1. Marketing Strategy

                22.4.9.7.2. Type Strategy

                22.4.9.7.3. Channel Strategy

        22.4.10. Hipro Biotechnology Co.,Ltd.

            22.4.10.1. Overview

            22.4.10.2. Type Portfolio

            22.4.10.3. Key Financials

            22.4.10.4. SWOT Analysis

            22.4.10.5. Key Developments

            22.4.10.6. Sales Footprint

            22.4.10.7. Strategy Overview

                22.4.10.7.1. Marketing Strategy

                22.4.10.7.2. Type Strategy

                22.4.10.7.3. Channel Strategy

        22.4.11. Vitrosens Biotechnology

            22.4.11.1. Overview

            22.4.11.2. Type Portfolio

            22.4.11.3. Key Financials

            22.4.11.4. SWOT Analysis

            22.4.11.5. Key Developments

            22.4.11.6. Sales Footprint

            22.4.11.7. Strategy Overview

                22.4.11.7.1. Marketing Strategy

                22.4.11.7.2. Type Strategy

                22.4.11.7.3. Channel Strategy

        22.4.12. bioMérieux SA

            22.4.12.1. Overview

            22.4.12.2. Type Portfolio

            22.4.12.3. Key Financials

            22.4.12.4. SWOT Analysis

            22.4.12.5. Key Developments

            22.4.12.6. Sales Footprint

            22.4.12.7. Strategy Overview

                22.4.12.7.1. Marketing Strategy

                22.4.12.7.2. Type Strategy

                22.4.12.7.3. Channel Strategy

        22.4.13. ELK Biotechnology CO.,Ltd.

            22.4.13.1. Overview

            22.4.13.2. Type Portfolio

            22.4.13.3. Key Financials

            22.4.13.4. SWOT Analysis

            22.4.13.5. Key Developments

            22.4.13.6. Sales Footprint

            22.4.13.7. Strategy Overview

                22.4.13.7.1. Marketing Strategy

                22.4.13.7.2. Type Strategy

                22.4.13.7.3. Channel Strategy

        22.4.14. Immuno-Biological Laboratories, Inc.

            22.4.14.1. Overview

            22.4.14.2. Type Portfolio

            22.4.14.3. Key Financials

            22.4.14.4. SWOT Analysis

            22.4.14.5. Key Developments

            22.4.14.6. Sales Footprint

            22.4.14.7. Strategy Overview

                22.4.14.7.1. Marketing Strategy

                22.4.14.7.2. Type Strategy

                22.4.14.7.3. Channel Strategy

        22.4.15. BISAF

            22.4.15.1. Overview

            22.4.15.2. Type Portfolio

            22.4.15.3. Key Financials

            22.4.15.4. SWOT Analysis

            22.4.15.5. Key Developments

            22.4.15.6. Sales Footprint

            22.4.15.7. Strategy Overview

                22.4.15.7.1. Marketing Strategy

                22.4.15.7.2. Type Strategy

                22.4.15.7.3. Channel Strategy

        22.4.16. Roche Diagnostics

            22.4.16.1. Overview

            22.4.16.2. Type Portfolio

            22.4.16.3. Key Financials

            22.4.16.4. SWOT Analysis

            22.4.16.5. Key Developments

            22.4.16.6. Sales Footprint

            22.4.16.7. Strategy Overview

                22.4.16.7.1. Marketing Strategy

                22.4.16.7.2. Type Strategy

                22.4.16.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Procalcitonin (PCT) Assay Market

Schedule a Call